| Course | DNRS 6501 Advanced Pathophysiology (DNP level) |
|---|---|
| Week | Week 3 |
| Paper type | Case analysis paper |
| Length | About 1,040 words, 6 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Doctor of Nursing Practice (DNP) |
| Updated | October 2026 |
Free sample paper for DNRS 6501 Week 3
Immune Complexes or Drug-Specific T Cells? A Case Analysis of Fever, Rash, and Eosinophilia on Day 24 of Vancomycin
Student Name
College of Nursing, Walden University
DNRS 6501: Advanced Pathophysiology (DNP level)
Instructor Name
Month Day, Year
Immune Complexes or Drug-Specific T Cells? A Case Analysis of Fever, Rash, and Eosinophilia on Day 24 of Vancomycin
The Presentation
A composite 61-year-old man is on day 24 of intravenous vancomycin for vertebral osteomyelitis. He has a temperature of 39.1 degrees Celsius, a confluent morbilliform rash over more than half of his body, facial swelling, and enlarged cervical and axillary lymph nodes. His eosinophil count is 2,100 per microliter with atypical lymphocytes on the smear. His alanine aminotransferase has risen to 212 units per liter while creatinine has climbed to 1.8 mg/dL from a baseline of 1.0; urine shows white cells without red cell casts and minimal protein. Serum C3 and C4 are normal. He reports no joint pain. He received a 10-day course of vancomycin 3 years ago without incident.
Two Candidate Mechanisms
Both of the following explanations are plausible, and each fits most of the picture.
Candidate A is a type III, immune complex reaction of the serum sickness kind. Antibodies form against the drug or a drug-protein complex, circulate as immune complexes, deposit in vessel walls, skin, joints, and kidneys, and activate complement. The classic prospective study of serum sickness described fever, skin eruptions, and joint pain, with falling complement levels and circulating immune complexes during the illness (Lawley et al., 1984).
Candidate B is a delayed, T-cell-mediated reaction, drug reaction with eosinophilia and systemic symptoms (DRESS). In the classification of delayed drug hypersensitivity, drug-specific T cells that secrete interleukin-5 recruit and activate eosinophils, the type described as IVb (Pichler, 2003). The reaction is systemic, involving skin, blood, and internal organs.
Finding by Finding
Each finding is taken once and assigned to the explanation it supports better.
Timing. Serum sickness after a first exposure usually begins 1 to 2 weeks after the drug is started. DRESS appears later; in the prospective RegiSCAR series, the median interval from drug start was 22 days, with an interquartile range of 17 to 31 days (Kardaun et al., 2013). Day 24 fits B well and A only at its outer edge. Supports B.
Eosinophil count. An eosinophil count of 2,100 per microliter is the finding a type IVb mechanism predicts, since interleukin-5 from drug-specific T cells drives eosinophil production and activation (Pichler, 2003). Eosinophilia was present in 95% of validated DRESS cases in the RegiSCAR series (Kardaun et al., 2013), while it is not a central feature of immune complex disease. Supports B.
Atypical lymphocytes and facial edema. Both are features of DRESS and are items in the RegiSCAR scoring system used to validate cases (Kardaun et al., 2007). Neither is characteristic of serum sickness. Supports B.
Liver and kidney involvement. Visceral involvement occurred in 91% of RegiSCAR DRESS cases (Kardaun et al., 2013), most often the liver. Immune complex disease can also injure the kidney, but through glomerular deposition, which produces red cell casts and proteinuria. His sediment shows white cells without red cell casts and little protein, a pattern that fits interstitial inflammation, the lesion DRESS produces. Supports B.
Complement. Serum sickness consumes complement, and falling C3 and C4 were among the laboratory findings in Lawley et al. (1984). His levels are normal. Supports B, and weighs against A directly.
Joint pain. Arthralgia is a prominent feature of serum sickness (Lawley et al., 1984). He has none. Supports B.
Fever and lymphadenopathy. These two findings genuinely support A, because both are typical of serum sickness. They do not exclude B, since high fever occurred in 90% and lymphadenopathy in 54% of DRESS cases (Kardaun et al., 2013), but they are the findings a defender of A would point to first, and they are the reason A deserved serious consideration.
Why the Immune Complex Explanation Loses
Candidate A is not dismissed because it is less familiar; it loses on three findings that it predicts and the case does not show. Normal complement, absent joint pain, and a urine sediment without red cell casts are each hard to reconcile with a reaction whose damage depends on complement-fixing immune complexes deposited in vessels, joints, and glomeruli. Its two supporting findings, fever and lymphadenopathy, are shared with DRESS and so cannot separate the two. By contrast, candidate B predicts the timing, the eosinophil count, the atypical lymphocytes, the facial edema, and the pattern of organ injury. The mechanism best supported is a delayed, T-cell-mediated reaction with eosinophil activation.
Why the Distinction Matters
Choosing between the two mechanisms is not an academic exercise. An immune complex reaction usually settles once the antigen is cleared, and its course is measured in days to a few weeks. A T-cell-mediated reaction of the DRESS type tends to be protracted: in the RegiSCAR series, the reaction was prolonged in all but two patients (Kardaun et al., 2013), and flares can follow a too-rapid taper of treatment. Survivors are also described as being at risk of later autoimmune disease, including thyroid disease, which calls for follow-up after the acute illness (Shiohara & Mizukawa, 2019). The mechanism therefore shapes how long he is watched, how slowly treatment is withdrawn, and what is checked months after discharge.
What the Chosen Mechanism Does Not Explain
One finding sits uneasily with the conclusion. He tolerated vancomycin 3 years ago. DRESS usually follows a first long course, and a T-cell mechanism would be expected to show itself on re-exposure sooner, not later. A partial answer is that the earlier course lasted only 10 days, shorter than the usual latency, so sensitization may have begun then without producing a reaction; another is that reactivation of herpesviruses, which is associated with DRESS, may shape when the syndrome declares itself (Shiohara & Mizukawa, 2019). Neither answer is proven for this patient.
What Would Change the Conclusion
Three results would reopen the comparison. Falling C3 and C4 on repeat testing, or circulating immune complexes, would strengthen A. A skin biopsy showing leukocytoclastic vasculitis rather than a lymphocytic infiltrate with eosinophils would do the same. In the other direction, testing for HLA-A*32:01 would strengthen B: in a case-control study, 19 of 23 patients with vancomycin-associated DRESS carried the allele, compared with none of 46 matched patients who tolerated vancomycin (Konvinse et al., 2019). An HLA association points to antigen presentation to T cells, which is the mechanism the analysis has chosen.
References
Kardaun, S. H., Sekula, P., Valeyrie-Allanore, L., Liss, Y., Chu, C. Y., Creamer, D., Sidoroff, A., Naldi, L., Mockenhaupt, M., Roujeau, J. C., & RegiSCAR Study Group. (2013). Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. British Journal of Dermatology, 169(5), 1071-1080. https://doi.org/10.1111/bjd.12501
Kardaun, S. H., Sidoroff, A., Valeyrie-Allanore, L., Halevy, S., Davidovici, B. B., Mockenhaupt, M., & Roujeau, J. C. (2007). Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? British Journal of Dermatology, 156(3), 609-611. https://doi.org/10.1111/j.1365-2133.2006.07704.x
Konvinse, K. C., Trubiano, J. A., Pavlos, R., James, I., Shaffer, C. M., Bejan, C. A., Schutte, R. J., Ostrov, D. A., Pilkinton, M. A., Rosenbach, M., Zwerner, J. P., Williams, K. B., Bourke, J., Martinez, P., Rwandamuriye, F., Chopra, A., Watson, M., Redwood, A. J., White, K. D., . . . Phillips, E. J. (2019). HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. Journal of Allergy and Clinical Immunology, 144(1), 183-192. https://doi.org/10.1016/j.jaci.2019.01.045
Lawley, T. J., Bielory, L., Gascon, P., Yancey, K. B., Young, N. S., & Frank, M. M. (1984). A prospective clinical and immunologic analysis of patients with serum sickness. The New England Journal of Medicine, 311(22), 1407-1413. https://doi.org/10.1056/NEJM198411293112204
Pichler, W. J. (2003). Delayed drug hypersensitivity reactions. Annals of Internal Medicine, 139(8), 683-693. https://doi.org/10.7326/0003-4819-139-8-200310210-00012
Shiohara, T., & Mizukawa, Y. (2019). Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergology International, 68(3), 301-308. https://doi.org/10.1016/j.alit.2019.03.006
The Walden DNRS 6501 Week 3 instructions
The third week usually presents a case and asks for an analysis built on mechanism. You identify at least two plausible explanations at the cellular or immune level, compare them against the actual findings, and argue for one. The prompt often adds a request to explain how the mechanism produces the signs and symptoms, and to note what further data would confirm or overturn the choice. Expect to write an APA 7 paper of several pages with a title page and references, drawing on primary studies or consensus criteria, not only the course text. Headings that follow the analysis, not the textbook's chapter order, help a grader see the argument. The case can be drawn from practice if identifying details are removed, though a composite is safer.
Inside the DNRS 6501 Week 3 example
Roughly four pages, with the presentation summarized once at the top in six lines and never repeated. Two candidate mechanisms are stated by the end of the first page, both plausible enough that a reader cannot tell which the paper will pick. The body then runs a comparison rather than two profiles: each finding from the case is taken up once and assigned to the explanation it supports, including the two findings that support the rejected candidate. A short section concedes what the chosen mechanism does not account for. Six references appear, weighted toward primary immunology literature rather than review chapters. Headings follow the argument instead of the assignment prompt, so the paper reads as a case being settled rather than as answers filed under questions.
DNRS 6501 Week 3 rubric: what earns full marks
Analyses lose credit by describing two mechanisms in sequence and calling that a comparison. The heaviest share follows whether findings are actually made to decide something, and a paper that never lets evidence cut against its preferred answer reads as a summary with a conclusion attached. Sections also weigh whether the rejected candidate was treated seriously, because a straw alternative makes the whole argument cheap. Source quality carries real weight at this level, and a reference list built from chapters and secondary summaries usually costs a band even when the reasoning is sound. Length overruns hurt more here than in a discussion, since compression is part of what is being assessed. Papers that restate the case in every section run out of room before the concession, which is where the strongest points sit.
DNRS 6501 Week 3 help: mistakes that cost marks
Papers on this case lose most of their credit by explaining type III and type IV hypersensitivity in two neat sections and never setting them against each other. The comparison has to happen finding by finding. Timing is the detail students skip most often, yet a reaction appearing after three weeks of therapy says something about mechanism. Another weak spot is claiming certainty the case cannot support; name what your chosen explanation leaves unexplained. Do not write treatment plans in detail, since this is a pathophysiology course, though one paragraph on why the distinction matters is fair. Cite the diagnostic criteria directly instead of a review that quotes them. Keep the case facts identical from the presentation to the conclusion. Finally, end on the result that would change your mind.
Get a DNRS 6501 Week 3 example written to your instructions
Send the case the classroom supplied, the page limit, and the rubric that will be applied, and an analysis built to argue rather than to summarize comes back to you. The first custom one is free and turns around in 24 to 48 hours. A patient you actually cared for is not the raw material here; composites do that work instead.
More DNRS 6501 papers and DNP samples
- DNRS 6501 Week 1: Discussion Post
- DNRS 6501 Week 2: Concept Map
- DNRS 6501 Week 4: Evidence Appraisal
- DNRS 6501 Week 5: Discussion Post
- DNRS 6501 Week 6: Pathophysiology Brief
- DNRS 6501 Week 7: Differential Analysis
- DNRS 6501 Week 8: Journal Club Critique
- DNRS 6501 Week 9: Discussion Post
- DNRS 6501 Week 10: Case Presentation
- DNRS 6501 Week 11: Synthesis Paper
- DNRS 6521 Week 3: Pharmacogenomic Memo
- NURS 6914 Week 3: Total pain case
- NURS 6001 Week 3: Boolean search trail
- NURS 6912 Week 3: Pain management plan
DNRS 6501 Week 3 questions, answered
Where in the term does a case analysis usually land?
Somewhere after the foundations and before the systems weeks, which in an eleven-week arc puts it in the vicinity of the third week. Walden does not publish the sequence, so treat that as a pattern rather than a promise. The structure holds wherever the assignment falls, because the comparison is what the doctoral rubric is reading for.
Can the two candidate mechanisms both be right?
Sometimes, and a paper arguing that they operate together can score well if it says which contributes what. What loses points is leaving the question open. A conclusion that names both and weighs neither reads as avoidance, and most rubrics carry a criterion asking the writer to take a position and stand behind it.
How is the composite case put together?
From published presentations and textbook patterns, combined so that no single real person is described. That is deliberate rather than cautious. Your own encounters stay in the record where they belong. Where a section hands out its own case, the example is built on that one rather than on any invention of ours.
Where can I find a free DNRS 6501 Week 3 sample paper?
The vancomycin case analysis is reproduced in full here, from the presentation and the two candidate mechanisms to the closing section on what would change the conclusion.
What does the DNRS 6501 Week 3 example conclude about the vancomycin reaction?
It argues for a drug-specific T cell response over an immune complex reaction, mainly on timing, the eosinophil count and organ findings, while admitting what that explanation does not cover.